World News: 13:00 GMT Tuesday 16th June 2015. [BIND Therapeutics, Inc. via Businesswire via SPi World News]
BIND Therapeutics Inc NASDAQ BIND a clinical-stage nanomedicine company developing targeted and programmable therapeutics called AccurinsTM announced today that Andrew Hirsch BINDs president and chief executive office...
Business Wire: 13:00 GMT Tuesday 16th June 2015
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.